News Novo Nordisk A/S Sao Paulo

Equities

N1VO34

BRN1VOBDR005

Market Closed - Sao Paulo Other stock markets 04:05:00 2024-06-12 pm EDT			5-day change	1st Jan Change
97.01 ^BRL	+20.21%		+3.65%	+55.29%

07:54pm	Novo Nordisk, Eli Lilly's Weight-Loss Drugs Coverage Dropped by Blue Cross Blue Shield of Michigan	MT
05:25pm	Global markets live: Apple, Oracle, Amazon, Boeing, Tesla...

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novo Nordisk, Eli Lilly's Weight-Loss Drugs Coverage Dropped by Blue Cross Blue Shield of Michigan	01:54pm	MT
Global markets live: Apple, Oracle, Amazon, Boeing, Tesla...	11:25am
Health Care Down as Rally Pauses -- Health Care Roundup	Jun. 11	DJ
Sector Update: Health Care Stocks Softer Late Afternoon	Jun. 11	MT
Novo Nordisk to Face Senate Panel Subpoena Vote Over Ozempic, Wegovy Prices	Jun. 11	MT
Sector Update: Health Care Stocks Decline Tuesday Afternoon	Jun. 11	MT
Sector Update: Health Care	Jun. 11	MT
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)	Jun. 11	AQ
Novo Nordisk President to Face Senate Panel Subpoena Vote Over Ozempic, Wegovy Prices	Jun. 11	MT
US Senate Committee to Subpoena Novo Nordisk Inc. President Over Prices of Diabetes, Obesity Drugs	Jun. 11	MT
Senate Committee to Vote June 18 to Subpoena Novo Nordisk President Doug Langa	Jun. 11	MT
US Senate panel to weigh Novo Nordisk subpoena over Ozempic, Wegovy prices	Jun. 11	RE
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development	Jun. 11	AQ
Dsm-firmenich sees boost as weight-loss drugs spur healthier choices	Jun. 10	RE
Argus Research Raises Novo Nordisk Price Target to $160 From $125, Maintains Buy Rating	Jun. 10	MT
Novo Nordisk A/S - share repurchase programme	Jun. 10	GL
Added health benefits of Wegovy, Zepbound could attract more men, doctors say	Jun. 10	RE
Novo Nordisk braces for Ozempic rivals in China	Jun. 06	RE
European equities gain on tech boost in run-up to ECB	Jun. 06	RE
Novo Nordisk Faces Competition in China for Key Ingredient in Diabetes, Weight Loss Drug	Jun. 06	MT